A real-life study of the medium to long-term effectiveness of a hypercaloric, hyperproteic enteral nutrition formula specifically for patients with diabetes on biochemical parameters of metabolic control and nutritional status

Autor: Ballesteros Pomar MD, Lardiés Sánchez B, Argente Pla M, Ramos Carrasco A, Suárez Gutiérrez L, Yoldi Arrieta A, Sorribes Carreras P, Gutiérrez Medina S, Molina Soria JB, Berrio Miranda M, Leyva Martínez MS, Torregrosa Suau O, Oliván Usieto MT, Villazón González F, Abilés Osinaga J, Martín Echevarría E, García-Malpartida K
Rok vydání: 2021
Předmět:
Zdroj: Endocrinologia, diabetes y nutricion
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Endocrinologia Diabetes y Nutricion
r-FISABIO. Repositorio Institucional de Producción Científica
ISSN: 2530-0180
Popis: Introduction: Although current recommendations suggest the use of specific formulas in enteral nutrition in people with diabetes, there is little evidence of their long-term effectiveness in glycemic control. The main objective of this study is to evaluate the long-term efficacy (24 weeks) of a specific high-protein hypercaloric enteral nutrition formula for people with diabetes in glycemic control and in their improvement in nutritional status. Methodology: This was a multicenter, prospective, observational, real-life study of patients with long-term enteral nutrition prescription through gastrostomy or nasogastric tube who received a high protein hypercaloric formula specific for diabetes. Once the participant's informed consent was obtained and the inclusion and exclusion criteria were verified, data relating to glycemic control, inflammation parameters, biochemical data, nutritional status and gastrointestinal tolerance at 0, 12 and 24 weeks were collected. Results: 112 patients were recruited, 44.6% women, age 75.0 (12.0) years and a mean time of evolution of diabetes of 18.1 (9.5) years. The percentage of patients with malnutrition according to VGS decreased throughout the treatment from 78.6% to 29.9% (P
Databáze: OpenAIRE
Externí odkaz: